Position in ZYME
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$87,892,353
+$2,007,843 QoQ
Shares Held
3,510,078
+7.6% QoQ
Ownership
4.81%
of shares outstanding
% of Portfolio
1.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,580,660,548 across 68 Biotechnology names. ZYME ranks #17 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in ZYME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-08 | $106,161,005 | 3,974,579 | Shares | Sole | 2026-04-15 | |
| 2026-03-31 | $87,892,353 | 3,510,078 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $85,884,510 | 3,261,850 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,708,524 | 2,090,663 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,004,688 | 1,275,274 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,208,243 | 1,864,672 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $31,183,492 | 2,130,020 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,359,251 | 2,180,020 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,192,220 | 1,667,711 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $11,306,969 | 1,074,807 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $11,167,244 | 1,074,807 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $9,168,419 | 1,446,123 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,876,244 | 2,416,232 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $30,541,621 | 3,378,498 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $35,458,621 | 4,511,275 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||